Antibodies Contract Manufacturing Market Size, Share, and Growth Forecast for 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Antibodies Contract Manufacturing Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2024 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Global Antibodies Contract Manufacturing Market Outlook
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2023
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2024 - 2032
   3. Global Antibodies Contract Manufacturing Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
         1. Monoclonal Antibodies
         2. Antibody Fragments
         3. Antibody-Drug Conjugates (ADCs)
         4. Others
      4. Market Attractiveness Analysis: Product
   4. Global Antibodies Contract Manufacturing Market Outlook: Expression System
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Expression System, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Expression System, 2024 - 2032
         1. Mammalian
         2. Microbial
            1. Bacteria
            2. Yeast
      4. Market Attractiveness Analysis: Expression System
   5. Global Antibodies Contract Manufacturing Market Outlook: Company Size
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Company Size, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Company Size, 2024 - 2032
         1. Small
         2. Mid-sized
         3. Large
         4. Very large
      4. Market Attractiveness Analysis: Company Size
   6. Global Antibodies Contract Manufacturing Market Outlook: Scale of Operation
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Scale of Operation, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2024 - 2032
         1. Preclinical
         2. Clinical
         3. Commercial
      4. Market Attractiveness Analysis: Scale of Operation
5. Global Antibodies Contract Manufacturing Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2023
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Antibodies Contract Manufacturing Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Expression System
      4. By Company Size
      5. By Scale of Operation
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Monoclonal Antibodies
      2. Antibody Fragments
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Expression System, 2024 - 2032
      1. Mammalian
      2. Microbial
         1. Bacteria
         2. Yeast
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Company Size, 2024 - 2032
      1. Small
      2. Mid-sized
      3. Large
      4. Very large
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2024 - 2032
      1. Preclinical
      2. Clinical
      3. Commercial
   8. Market Attractiveness Analysis
7. Europe Antibodies Contract Manufacturing Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Expression System
      4. By Company Size
      5. By Scale of Operation
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Monoclonal Antibodies
      2. Antibody Fragments
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Expression System, 2024 - 2032
      1. Mammalian
      2. Microbial
         1. Bacteria
         2. Yeast
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Company Size, 2024 - 2032
      1. Small
      2. Mid-sized
      3. Large
      4. Very large
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2024 - 2032
      1. Preclinical
      2. Clinical
      3. Commercial
   8. Market Attractiveness Analysis
8. East Asia Antibodies Contract Manufacturing Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Expression System
      4. By Company Size
      5. By Scale of Operation
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Monoclonal Antibodies
      2. Antibody Fragments
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Expression System, 2024 - 2032
      1. Mammalian
      2. Microbial
         1. Bacteria
         2. Yeast
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Company Size, 2024 - 2032
      1. Small
      2. Mid-sized
      3. Large
      4. Very large
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2024 - 2032
      1. Preclinical
      2. Clinical
      3. Commercial
   8. Market Attractiveness Analysis
9. South Asia & Oceania Antibodies Contract Manufacturing Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Expression System
      4. By Company Size
      5. By Scale of Operation
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Monoclonal Antibodies
      2. Antibody Fragments
      3. Antibody-Drug Conjugates (ADCs)
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Expression System, 2024 - 2032
      1. Mammalian
      2. Microbial
         1. Bacteria
         2. Yeast
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Company Size, 2024 - 2032
      1. Small
      2. Mid-sized
      3. Large
      4. Very large
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2024 - 2032
      1. Preclinical
      2. Clinical
      3. Commercial
   8. Market Attractiveness Analysis
10. Latin America Antibodies Contract Manufacturing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       1. By Country
       2. By Product
       3. By Expression System
       4. By Company Size
       5. By Scale of Operation
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
       1. Monoclonal Antibodies
       2. Antibody Fragments
       3. Antibody-Drug Conjugates (ADCs)
       4. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Expression System, 2024 - 2032
       1. Mammalian
       2. Microbial
          1. Bacteria
          2. Yeast
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Company Size, 2024 - 2032
       1. Small
       2. Mid-sized
       3. Large
       4. Very large
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2024 - 2032
       1. Preclinical
       2. Clinical
       3. Commercial
    8. Market Attractiveness Analysis
11. Middle East & Africa Antibodies Contract Manufacturing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       1. By Country
       2. By Product
       3. By Expression System
       4. By Company Size
       5. By Scale of Operation
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
       1. Monoclonal Antibodies
       2. Antibody Fragments
       3. Antibody-Drug Conjugates (ADCs)
       4. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Expression System, 2024 - 2032
       1. Mammalian
       2. Microbial
          1. Bacteria
          2. Yeast
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Company Size, 2024 - 2032
       1. Small
       2. Mid-sized
       3. Large
       4. Very large
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2024 - 2032
       1. Preclinical
       2. Clinical
       3. Commercial
    8. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Lonza
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Boehringer Ingelheim International GmbH
       3. Emergent
       4. Eurofins Scientific
       5. Thermo Fisher Scientific
       6. AbbVie Inc.
       7. Catalent Inc.
       8. KBI Biopharma
       9. Aldevron
       10. Novasep
       11. Nitto Avecia Pharma Services
       12. Pierre Fabre
       13. Samsung Biologics
       14. Synthon
       15. WuXi Biologics
       16. Charles River Laboratories
       17. FUJIFILM Holdings Corporation
       18. mAbxience
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations